All News #Library
Biotech
Repare Shareholders Approve Acquisition By Xenotherapeutics
17 Jan 2026 //
BUSINESSWIRE
Repare Partners with Debiopharm for PKMYT1 Inhibitor
16 Jul 2025 //
FIERCE BIOTECH
Repare Out-Licenses Discovery Platforms to DCx Biotherapeutics
01 May 2025 //
BUSINESSWIRE
Repare Therapeutics: Six Abstracts Accepted at AACR 2025
25 Apr 2025 //
BUSINESSWIRE
Repare cans plans for phase 3 cancer combo trial
10 Jan 2025 //
FIERCE BIOTECH

Market Place
Sourcing Support